Skip to main content

Table 3 The characteristics of the various types of DM and ICI-DM

From: Distinct changes to pancreatic volume rather than pancreatic autoantibody positivity: insights into immune checkpoint inhibitors induced diabetes mellitus

 

FT1DM [7]

Classic T1D [8]

ICI-induced diabetes [25]

Our study

Clinical features

Ethnicity

Asian

Mostly non-Asian

Both Asian and non-Asian

Taiwan

Honeymoon

No

68.9% (71/103) [37]

No

No

Ketoacidosis

100.0%

38.8% (285/735) [38]

67.5% (135/200)

60.0% (6/10)

Permanent insulin required

Yes

Yes

98% (152/155)

100% (10/10)

Biochemical features (at diagnosis)

C-peptide

Low or undetectable

Progressive decline, 48% maintain stimulated C-peptide > 0.2nmol/L at 5 years

63% (83/131) low or undetectable

Low or undetectable: 100% (10/10)

HbA1c

(mmol/mol) (range)

46 (37–56) [39]

> 46 [40]

62 (40–120)

72 (46–101)

Lipase elevation

85% (50/59) [39]

24% (36/150) [41]

52% (13/25) [7]

20% (1/5)

Anti-GAD autoantibodies

5% (7/145) [39]

89% (114/128) [39]

43% (65/151)

10% (1/10)

Pancreas image

Undiminished pancreatic volume [42]

Pancreatic volume decreased compared with controls [43]

11% (4/36) with pancreatic atrophy [25]

90% (9/10) with pancreatic atrophy

  1. Abbreviations: FT1DM, fulminant type 1 diabetes mellitus; T1D, type 1 diabetes mellitus; ICI, Immune checkpoint inhibitor; HbA1c, glycated hemoglobulin; Ab, antibody; Anti-GAD, Glutamic acid decarboxylase antibodies